EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson’s disease, and progressive supranuclear palsy: a cross-comparative investigation

Megha Murthy, Katherine Fodder, Yasuo Miki, Naiomi Rambarack, Eduardo De Pablo Fernandez, Lasse Pihlstrøm, Jonathan Mill, Thomas T Warner, Tammaryn Lashley, Conceição Bettencourt iD

Acta Neuropathologica · 2024

DOI: 10.1007/s00401-024-02764-4 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Acta Neuropathologica, 2024. Verfasst von Megha Murthy und 9 weiteren Autor:innen. Beteiligte Einrichtung: Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK. Hauptthemen laut MEDLINE: Supranuclear Palsy, Progressive, DNA Methylation, Multiple System Atrophy, White Matter. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Multiple System Atrophy Trust, South-Eastern Norway Regional Health Authority.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple system atrophy (MSA) is a rare neurodegenerative disease characterized by neuronal loss and gliosis, with oligodendroglial cytoplasmic inclusions (GCIs) containing α-synuclein being the primary pathological hallmark. Clinical presentations of MSA overlap with other parkinsonian disorders, such as Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and progressive supranuclear palsy (PSP), posing challenges in early diagnosis. Numerous studies have reported alterations in DNA methylation in neurodegenerative diseases, with candidate loci being identified in various parkinsonian disorders including MSA, PD, and PSP. Although MSA and PSP present with substantial white matter pathology, alterations in white matter have also been reported in PD. However, studies comparing the DNA methylation architectures of white matter in these diseases are lacking. We therefore aimed to investigate genome-wide DNA methylation patterns in the frontal lobe white matter of individuals with MSA ( n = 17), PD ( n = 17), and PSP ( n = 16) along with controls ( n = 15) using the Illumina EPIC array, to identify shared and disease-specific DNA methylation alterations. Genome-wide DNA methylation profiling of frontal lobe white matter in the three parkinsonian disorders revealed substantial commonalities in DNA methylation alterations in MSA, PD, and PSP. We further used weighted gene correlation network analysis to identify disease-associated co-methylation signatures and identified dysregulation in processes relating to Wnt signaling, signal transduction, endoplasmic reticulum stress, mitochondrial processes, RNA interference, and endosomal transport to be shared between these parkinsonian disorders. Our overall analysis points toward more similarities in DNA methylation patterns between MSA and PD, both synucleinopathies, compared to that between MSA and PD with PSP, which is a tauopathy. Our results also highlight several shared DNA methylation changes and pathways indicative of converging molecular mechanisms in the white matter contributing toward neurodegeneration in all three parkinsonian disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Supranuclear Palsy, ProgressiveDNA MethylationMultiple System AtrophyWhite MatterParkinson DiseaseFrontal LobeHumansAgedFemaleMaleMiddle AgedAged, 80 and over

Stichwörter der Autor:innen

DNA methylationEWASMultiple system atrophyParkinsonian disordersParkinson’s diseaseProgressive supranuclear palsyWGCNA

Autor:innen und Institutionen

  • Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.
  • Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.
  • Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
  • Department of Neuropathology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, UK.
  • Department of Neurology, Oslo University Hospital, Oslo, Norway.

ORCID-Profile: Conceição Bettencourt

Förderung

  • Medical Research Council
  • Multiple System Atrophy Trust
  • South-Eastern Norway Regional Health Authority
  • Alzheimer’s Research UK
  • Alzheimer Society
  • Reta Lila Weston Institute of Neurological Studies, UCL Queen Square Institute of Neurology,University College London

Zitieren

APA

Murthy, M., Fodder, K., Miki, Y., Rambarack, N., De Pablo Fernandez, E., Pihlstrøm, L., Mill, J., Warner, T. T., Lashley, T., & Bettencourt, C. (2024). DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson’s disease, and progressive supranuclear palsy: a cross-comparative investigation. Acta Neuropathologica. https://doi.org/10.1007/s00401-024-02764-4

Vancouver

Murthy M, Fodder K, Miki Y, Rambarack N, De Pablo Fernandez E, Pihlstrøm L, et al. DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson’s disease, and progressive supranuclear palsy: a cross-comparative investigation. Acta Neuropathologica. 2024. doi:10.1007/s00401-024-02764-4

BibTeX
@article{Murthy2024,
  author = {Murthy, Megha and Fodder, Katherine and Miki, Yasuo and Rambarack, Naiomi and De Pablo Fernandez, Eduardo and Pihlstrøm, Lasse and Mill, Jonathan and Warner, Thomas T and Lashley, Tammaryn and Bettencourt, Conceição},
  title = {DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson’s disease, and progressive supranuclear palsy: a cross-comparative investigation},
  journal = {Acta Neuropathologica},
  year = {2024},
  doi = {10.1007/s00401-024-02764-4}
}
Kostenlos starten →